Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.3M
-62.2% from 2023
Prescriptions
198
$6,739.29 per claim
Patients
29
31 prescribers
Total spending, 2024
$1.3M
$46,013.12 per patient
Medicare prescription drug plans paid $1.3M for Iressa in 2024, for 198 prescriptions and refills to 29 patients (down 62.2% from 2023). The average cost per claim was $6,739.29.
California had the highest Medicare cost for Iressa in 2024: $329K for 51 claims, followed by Washington ($178K).
Sai-Hong I Ou, internal medicine in Orange, CA, had the highest Medicare cost for Iressa in 2024: 24 claims costing $175K.
Iressa is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sai-Hong I Ou Orange, CA | Internal Medicine | 24 | Under 11 | $175K |
| Deepti Behl Rochester, MN | Hematology-Oncology | 13 | Under 11 | $105K |
| Mazen Khalil Jonesboro, AR |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 140 | 809 | 133 | $6.6M |
| 2023 | 89 | 428 | 90 | $3.5M |
| 2024 | 31 | 198 | 29 | $1.3M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 14 |
| Under 11 |
| $99K |
| Kimberly W Hardin New Albany, MS | Nurse Practitioner | 12 | Under 11 | $93K |
| George R Simon Celebration, FL | Medical Oncology | 12 | Under 11 | $92K |
| Jason Kao Stanford, CA | Physician Assistant | 12 | Under 11 | $89K |
| Arpeet T Shah Castro Valley, CA | Medical Oncology | 13 | Under 11 | $48K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 198 | $1.3M |